Nestle invests $98M in Aimmune

The Nestle Health Science subsidiary of Nestle S.A. (SIX:NESN) will invest $98 million in Aimmune Therapeutics Inc. (NASDAQ:AIMT) through the purchase of 3.2 million shares at $30.27. The price is a slight discount to Aimmune’s close of $30.29 on Nov. 9, before the offering was announced.

The financing is expected to close by year end. It will bring Nestle’s investment in the food allergy company to $273 million, representing a 19% stake...